Shield Therapeutics (SHIEF, $0.02) was a top loser over the last three months, falling -2 to $0.02 per share. A.I.dvisor analyzed 278 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending June 3, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.